Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Short Communication

Oxidative Damage by 3-nitrotyrosine in Young Adults with Obesity: Its Implication in Chronic and Contagious Diseases

Author(s): Claudia Marissa Calderón-Torres*, Ana E. Ortiz-Reyes and Miguel Murguía-Romero

Volume 23, Issue 4, 2023

Published on: 31 May, 2022

Page: [358 - 364] Pages: 7

DOI: 10.2174/1566524022666220324114027

Price: $65

Abstract

Introduction: Cellular damage by oxidation occurs in numerous chronic diseases, such as obesity, type II diabetes, cardiovascular disease, nonalcoholic fatty liver, etc. The oxidized compound 3-nitrotyrosine is a marker of oxidative stress and protein oxidation damage.

Objective: The article aims to assess whether 3-nitrotyrosine levels are higher in young people with obesity than in the same population without obesity.

Methods: Anthropometry and blood chemistry analyses were performed on 24 young Mexican participants (18-30 years old), categorized into two groups based on their waist circumference: Withobesity (≥ 80 cm women; ≥ 90 cm men) and without-obesity (<80 cm women; <90 cm men). Additionally, 3-nitrotyrosine blood values were quantified by ELISA.

Results: Except for HDL-cholesterol, the mean values of lipids increased in women and men with obesity (p<0.05), and 3-nitrotyrosine concentration (nM/μg total protein) was higher by 60% in the group with-obesity compared to the group without-obesity, both for women (66.21 ± 23.85 vs. 40.69 ± 16.25, p<0.05) and men (51.72 ± 20.56 vs. 30.52 ± 5.21, p<0.05).

Conclusion: Oxidative damage measured by compound 3-nitrotyrosine was higher in the group with obesity than in the group without obesity, which, if not controlled, could lead to a chronic oxidative condition and thereby to a degree of cellular aging with adverse health effects.

Keywords: Oxidative stress, 3-NT, Excess lipids, Protein damage, type 2 diabetes, cellular damage.

« Previous Next »
[1]
Fujita H, Sakamoto T, Komatsu K, et al. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy. Hypertens Res 2011; 34(12): 1302-8.
[http://dx.doi.org/10.1038/hr.2011.127] [PMID: 21814206]
[2]
Zhang XG, Zhang YQ, Cheng QP, Cao Y, Sun JM, Lv XF. The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy. Eur J Med Res 2018; 23(1): 7.
[http://dx.doi.org/10.1186/s40001-018-0304-2] [PMID: 29433562]
[3]
Bandookwala M, Sengupta P. 3-Nitrotyrosine: A versatile oxidative stress biomarker for major neurodegenerative diseases. Int J Neurosci 2020; 130(10): 1047-62.
[http://dx.doi.org/10.1080/00207454.2020.1713776] [PMID: 31914343]
[4]
Garcia-Garcia A, Rodriguez-Rocha H, Madayiputhiya N, Pappa A, Panayiotidis MI, Franco R. Biomarkers of protein oxidation in human disease. Curr Mol Med 2012; 12(6): 681-97.
[http://dx.doi.org/10.2174/156652412800792543] [PMID: 22292436]
[5]
Catalán-García M, García-García FJ, Moreno-Lozano PJ, et al. Mitochondrial dysfunction: a common hallmark underlying comorbidity between sibm and other degenerative and age-related diseases. J Clin Med 2020; 9(5): 1446.
[http://dx.doi.org/10.3390/jcm9051446] [PMID: 32413985]
[6]
Jin K. Modern biological theories of aging. Aging Dis 2010; 1(2): 72-4.
[PMID: 21132086]
[7]
Teixeira D, Fernandes R, Prudêncio C, Vieira M. 3-Nitrotyrosine quantification methods: Current concepts and future challenges. Biochemie 2016; 125: 1-11.
[http://dx.doi.org/10.1016/j.biochi.2016.02.011] [PMID: 26921794]
[8]
Ischiropoulos H. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356(1): 1-11.
[http://dx.doi.org/10.1006/abbi.1998.0755] [PMID: 9681984]
[9]
Vattemi G, Mechref Y, Marini M, et al. Increased protein nitration in mitochondrial diseases: Evidence for vessel wall involvement. Mol Cell Proteomics 2011; 10(4) M110.002964.
[http://dx.doi.org/10.1074/mcp.M110.002964]
[10]
Gochman E, Mahajna J, Shenzer P, et al. The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochem 2012; 114(8): 827-35.
[http://dx.doi.org/10.1016/j.acthis.2012.02.004] [PMID: 22417974]
[11]
Calderón-Torres CM, Sarabia-Curz L, Ledesma-Soto Y, Murguía-Romero M, Terrazas LI. Denitrase activity of Debaryomyces hansenii reduces the oxidized compound 3-nitrotyrosine in mice liver with colitis. Exp Ther Med 2019; 17(5): 3748-54.
[http://dx.doi.org/10.3892/etm.2019.7395] [PMID: 31007730]
[12]
Ortiz-Reyes AE, Calderón-Torres CM. Increased expression of TLR4 and antioxidant effect of acetylsalicylic acid in rabbits with a high-fat diet. RESPYN Revista Salud Pública y Nutrición 2017; 16(2): 1-10.
[http://dx.doi.org/10.29105/respyn16.2-1]
[13]
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: Process, indicators, risk factors and new hopes. Int J Prev Med 2014; 5(8): 927-46.
[PMID: 25489440]
[14]
Yang X, Li Y, Li Y, et al. Oxidative stress-mediated atherosclerosis: Mechanisms and therapies. Front Physiol 2017; 8: 600.
[http://dx.doi.org/10.3389/fphys.2017.00600] [PMID: 28878685]
[15]
Weber D, Kneschke N, Grimm S, Bergheim I, Breusing N, Grune T. Rapid and sensitive determination of protein-nitrotyrosine by ELISA: Application to human plasma. Free Radic Res 2012; 46(3): 276-85.
[http://dx.doi.org/10.3109/10715762.2011.652627] [PMID: 22276750]
[16]
Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med 2015; 373(14): 1307-17.
[http://dx.doi.org/10.1056/NEJMoa1502821] [PMID: 26422721]
[17]
National institute of public health and ministry of health. national health and nutrition survey (ENSANUT). Available from http://promocion.salud.gob.mx/dgps/descargas1/doctos_2016/ensanut_mc_2016-310oct.pdf
[18]
Fernández-Rojas MA, Luna-Ruiz Esparza MA, Campos-Romero A, et al. Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people. Int J Infect Dis 2021; 104: 572-9.
[http://dx.doi.org/10.1016/j.ijid.2020.12.086] [PMID: 33434668]
[19]
Stanley BA, Van Eyk JE. A method for the effective depletion of albumin from cellular extracts: Application to human myocardium. Methods Mol Biol 2007; 357: 67-70.
[http://dx.doi.org/10.1385/1-59745-214-9:67] [PMID: 17172679]
[20]
Murguía-Romero M, Jiménez-Flores JR, Méndez-Cruz AR, Sigrist-Flores SC, Villalobos-Molina R. Insulin and HOMA-IR in healthy young mexicans: A cut-off points proposal. Intern Med Open Access 2014; S6(s6): 1-5.
[http://dx.doi.org/10.4172/2165-8048.S6-001]
[21]
Korovila I, Höhn A, Jung T, Grune T, Ott C. Reduced liver autophagy in high-fat diet induced liver steatosis in new zealand obese mice. Antioxidants 2021; 10(4): 501.
[http://dx.doi.org/10.3390/antiox10040501] [PMID: 33804819]
[22]
Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88(6): 1785-92.
[http://dx.doi.org/10.1172/JCI115499] [PMID: 1752940]
[23]
Potor L, Nagy P, Méhes G, et al. Hydrogen sulfide abrogates hemoglobin-lipid interaction in atherosclerotic lesion. Oxid Med Cell Longev 2018; 2018: 3812568.
[http://dx.doi.org/10.1155/2018/3812568] [PMID: 29560080]
[24]
Sergiev PV, Dontsova OA, Berezkin GV. Theories of aging: An ever-evolving field. Acta Nat (Engl Ed) 2015; 7(1): 9-18.
[http://dx.doi.org/10.32607/20758251-2015-7-1-9-18] [PMID: 25926998]
[25]
Pamukçu B. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. Anatol J Cardiol 2020; 24(4): 224-34.
[http://dx.doi.org/10.14744/AnatolJCardiol.2020.56727] [PMID: 33001051]
[26]
McCallum M, Bassi J, De Marco A, et al. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science 2021; 373(6555): 648-54.
[http://dx.doi.org/10.1126/science.abi7994] [PMID: 34210893]
[27]
Wilmot EG, Leggate M, Khan JN, et al. Type 2 diabetes mellitus and obesity in young adults: The extreme phenotype with early cardiovascular dysfunction. Diabet Med 2014; 31(7): 794-8.
[http://dx.doi.org/10.1111/dme.12431] [PMID: 24606573]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy